Medtronic stock sheds 2.32% and underperforms rivals
Updated
Updated · MarketWatch · May 8
Medtronic stock sheds 2.32% and underperforms rivals
11 articles · Updated · MarketWatch · May 8
Shares closed at $76.15 as the S&P 500 rose 0.84% to 7,398.93 and the Dow Jones Industrial Average edged up 0.02% to 49,609.16.
Medtronic ended 28.38% below its 52-week high of $106.33 reached on 26 November. Johnson & Johnson fell 0.53%, Danaher 2.56% and Abbott Laboratories 3.09%.
Trading volume reached 9.0 million shares, above Medtronic's 50-day average of 8.7 million, indicating heavier-than-usual activity despite the broader market's gains.
Amidst fierce competition and GLP-1 drug threats, can Medtronic's high-tech turnaround truly succeed?
With rivals launching similar tech, how long can Medtronic's lead in the booming heart ablation market last?
Medtronic's Hugo robot is challenging a surgical giant. Does it have what it takes to win in the operating room?